Special NoticePosted Jul 30, 2026·Responses due Aug 20, 2026

Multiscale Reasoning For Human Physiology RFI

DARPA · DEF ADVANCED RESEARCH PROJECTS AGCY

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
541714
Value
Not stated
Solicitation
DARPA-SN-26-100
Set-aside
None stated
PSC
AC12
Place
Not stated
Contact
Dr. Roozbeh Jafari, Program Manager, DARPA/BTO (bioreasoning@darpa.mil)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation DARPA-SN-26-100 in this department, oldest first.

Early notice
  • Jul 13, 2026
    Special Notice
    Open
  • Jul 30, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (2 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

UPDATE: The purpose of Amendment 1 to DARPA-SN-26-100, the Multiscale Reasoning For Human Physiology RFI Special Notice (SN), is to extend the notice deadline. The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is issuing this Request for Information (RFI) to solicit input from industry, academia, government laboratories, healthcare organizations, and non-traditional performers regarding emerging technologies, datasets, computational frameworks, artificial intelligence systems, and foundation models that enable multiscale reasoning across human physiolog… (show all)

y.

Who won similar work

6 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 541714.

WinnerAwardsValueLast
NATIONAL COLLEGIATE INVENTORS & INNOVATORS ALLIANCE, INC.2$2.4MJun 23, 2026
UNIVERSITY OF MARYLAND, COLLEGE PARK1$11.2MNov 26, 2024
ENGINEERING BIOLOGY RESEARCH CONSORTIUM Emeryville CA 94608 USA1$1.2MJun 23, 2026
REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC.1$1.2MOct 5, 2026
The Council on Strategic Risks Washington DC 20036 USA1$693KOct 21, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Defense Advanced Research Projects Agency (DARPA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Defense Advanced Research Projects Agency (DARPA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.